CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $195M invested in Concert Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less call options, than puts
Call options by funds: $572K | Put options by funds: $1.08M
Holders
79
Holding in Top 10
2
Calls
$572K
Puts
$1.08M
Top Buyers
| 1 | +$6.63M | |
| 2 | +$4.87M | |
| 3 | +$2.23M | |
| 4 |
QI
QS Investors
New York
|
+$1.29M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.04M |
Top Sellers
| 1 | -$6.69M | |
| 2 | -$2.79M | |
| 3 | -$2.16M | |
| 4 |
PC
Paulson & Co
New York
|
-$1.2M |
| 5 |
AIC
AWM Investment Company
New York
|
-$1.17M |